查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2030234

乳房X光攝影設備市場－全球產業規模、佔有率、趨勢、機會和預測：按產品類型、技術、最終用戶、地區和競爭格局分類，2021-2031年

Mammography Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product Type, By Technology, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球乳房X光攝影設備市場預計將從2025年的31.3億美元成長到2031年的44.7億美元，複合年成長率為6.12%。

這些重要的醫學影像設備，包括數位乳房X光乳房X光攝影和乳房斷層合成影像，利用低劑量X光產生乳房組織的高解析度影像，有助於乳癌的早期發現和診斷。市場成長的主要驅動力是全球乳癌發生率的上升，以及人們對早期診斷和定期篩檢計畫的認知不斷提高。此外，全球女性人口老化和政府對促進乳房健康的支持也對市場的持續成長起到了重要作用。

市場概覽
預測期 2027-2031
市場規模：2025年 31.3億美元
市場規模：2031年 44.7億美元
複合年成長率：2026-2031年 6.12%
成長最快的細分市場 數位乳房X光攝影
最大的市場 北美洲

市場擴張的一大障礙是全球缺乏訓練有素的放射科醫生和操作這些設備並準確分析結果所需的關鍵醫療專業人員。然而，乳癌發生率的不斷上升凸顯了這些系統的不可或缺性。美國癌症協會預測，到2026年，美國將有約321,910名女性被診斷出患有侵襲性乳癌，這更凸顯了早期診斷技術的迫切需求。

市場促進因素

全球乳癌發生率的不斷上升是乳房X光攝影設備市場成長的主要驅動力。發病率的上升使得早期檢測策略的廣泛應用成為必要，以提高存活率和患者的整體預後。全球疾病負擔研究乳癌合作小組於2026年3月在《柳葉刀腫瘤學》雜誌上發表的一項分析估計，2023年全球將有230萬女性新確診患有乳癌，這凸顯了對可靠診斷設備的持續迫切需求。這項普遍存在的健康問題正促使世界各地的醫療機構提升篩檢能力，並積極推廣採用最先進的乳房乳房X光攝影系統。

另一個關鍵因素是影像設備的持續技術進步，這些進步不斷提升乳房X光攝影的效能和功能。諸如3D斷層合成和人工智慧診斷等技術進步，提高了影像解析度，減少了複查頻率，並增強了對微小病灶的識別精度，從而推動了醫療機構的系統升級和新設備的部署。為了體現對科技進步的執著，西門子醫療將在2024年至2025年間投資約20億歐元用於研發，以確保其影像產品線的持續改善。此類技術進步對於吸引投資和擴大市場佔有率至關重要。此外，為了展現政府和業界在推動乳癌治療方面的共同承諾，亞伯達省政府於2025年3月宣布與西門子醫療和亞伯達癌症基金會合作，在未來八年內投資8億加元，用於改善癌症治療和促進早期檢測。

市場挑戰

全球乳房X光攝影設備市場成長面臨的主要障礙之一是合格放射科醫生和關鍵醫務人員的短缺，這些人員對於正確操作設備和解讀觀察至關重要。儘管早期檢測的需求日益成長，但這種短缺直接限制了醫療機構進行診斷評估和乳癌篩檢的能力。缺乏合格的專業人員嚴重阻礙了先進乳房X光攝影設備（例如最新的數位和斷層合成系統）的最佳利用。

因此，醫療機構可能會延遲或減少篩檢頻率，導致現有設備利用率不足，不願投資新技術，最終減緩市場發展。乳房攝影學會2026年的調查顯示，79%的醫療機構面臨乳房攝影領域人員短缺的問題。這一常見的人員問題降低了乳房X光檢查診所的運作能力，給尋求必要篩檢服務的患者造成了重大障礙，並直接阻礙了市場的發展趨勢。

市場趨勢

改變全球乳房X光攝影設備市場的最重要趨勢之一是人工智慧（AI）在診斷操作中的日益普及，這不僅提高了效率，也增強了臨床診斷的準確性。人工智慧演算法正被更頻繁地用於處理重複性任務、優先處理高風險患者以及輔助決策，從而最佳化綜合篩檢流程。這種應用有助於緩解放射科醫生短缺的問題，並應對篩檢量的激增。例如，發表於2026年3月《自然·癌症》雜誌的GEMINI研究表明，在英國，將人工智慧融入篩檢作業可減少高達31%的工作量。這種效率的提升將使醫療專業人員能夠利用現有資源處理更多病例，從而加快患者就診速度，並提高患者獲得快速診斷的機會。

另一個重要趨勢是專業影像技術的穩定發展，特別是分子乳房成像和造影乳房X光攝影。這些系統提供了重要的二級篩檢選擇，尤其適用於乳房組織緻密的患者，因為緻密乳房組織可能會限制標準乳房X光攝影的有效性。造影乳房X光攝影透過可視化可疑病灶內的血流來提供功能性訊息，而分子乳房影像則使用放射性示蹤劑來識別代謝活躍的癌細胞。在2026年ARRS會議上發表的一項對Density MATTERS試驗的2025年回顧顯示，在數位乳房斷層合成成像之後進行分子乳房成像，每年每1000例檢查可額外發現6.7例癌症。這些技術進步正在拓展診斷選擇，並為高度個人化和有效的乳癌篩檢方法鋪平道路。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球乳房X光攝影設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（全視野數位乳房X乳房X光攝影、底片/屏乳房X光乳房X光攝影、乳房斷層合成）
    • 按技術（數位、類比）
    • 依最終使用者（醫院/診所、診斷中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美乳房X光攝影設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲乳房X光攝影設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區乳房X光攝影設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲乳房X光攝影設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲乳房X光攝影設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球乳房X光攝影設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Hologic Inc.
  • Fujifilm Holdings Corporation
  • Philips Healthcare
  • Siemens Healthineers AG
  • GE Healthcare
  • Carestream Health Inc.
  • Konica Minolta Inc.
  • Delphinus Medical Technologies Inc.
  • Analogic Corporation
  • KUB Technologies Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7346

The Global market for mammography devices is anticipated to expand from USD 3.13 billion in 2025 to USD 4.47 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.12%. These critical medical imaging instruments, which include digital mammography and breast tomosynthesis, use low-dose X-rays to generate highly detailed images of breast tissue for the preliminary detection and diagnosis of breast cancer. Market growth is mainly fueled by the climbing worldwide rate of breast cancer cases, along with heightened awareness regarding early diagnosis and routine screening programs. Additionally, an aging global female demographic and favorable government programs advocating for breast health play a major role in driving ongoing market growth.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.13 Billion
Market Size 2031USD 4.47 Billion
CAGR 2026-20316.12%
Fastest Growing SegmentDigital Mammography
Largest MarketNorth America

A significant obstacle to market expansion is the worldwide scarcity of properly trained radiologists and essential medical personnel required to operate these devices and accurately analyze the results. Nevertheless, the rising frequency of breast cancer emphasizes the indispensable nature of these systems. The American Cancer Society projects that around 321,910 women in the United States will receive an invasive breast cancer diagnosis in 2026, underscoring the urgent necessity for early diagnostic technologies.

Market Driver

The escalating worldwide rate of breast cancer serves as a major driving force behind the growth of the mammography devices market. This growing frequency requires the broad implementation of early detection strategies to enhance survival rates and overall patient outcomes. A March 2026 analysis by the Global Burden of Disease Study Breast Cancer Collaborators, featured in The Lancet Oncology, estimated that 2.3 million new cases of breast cancer were diagnosed in women globally in 2023, highlighting a strong and continuous need for reliable diagnostic equipment. This widespread health issue motivates healthcare facilities around the world to upgrade their screening capacities, stimulating the acquisition of cutting-edge mammography systems.

Another key driver is the constant technological progression in imaging equipment, which continually transforms the effectiveness and functionality of mammography. Breakthroughs like 3D tomosynthesis and AI-driven diagnostics provide greater image resolution, lower recall frequencies, and better identification of minor lesions, prompting facilities to upgrade or install new systems. Emphasizing this dedication to progress, Siemens Healthineers is channeling roughly €2 billion into research and development between 2024 and 2025 to ensure ongoing product enhancements within its imaging lineup. Such technological strides are vital for drawing investments and deepening market reach. Additionally, showcasing a joint governmental and industry resolve to advance breast cancer treatment, the government of Alberta partnered with Siemens Healthineers and the Alberta Cancer Foundation in March 2025 to declare an $800 million CAD investment over eight years aimed at elevating cancer care and facilitating early detection.

Market Challenge

A major hurdle hindering the growth of the global mammography devices market is the lack of sufficiently trained radiologists and key medical staff needed to correctly operate the equipment and interpret the findings. This deficit immediately limits the ability of medical centers to perform diagnostic evaluations and breast cancer screenings, even as the desire for early detection grows. With a shortage of competent professionals, the optimal use of sophisticated mammography machinery, such as modern digital and tomosynthesis platforms, is significantly undermined.

Consequently, healthcare facilities might postpone or decrease the number of screening sessions, which causes current devices to be underused and creates hesitation toward investing in novel technologies, ultimately slowing market progress. A 2026 survey conducted by the Society of Breast Imaging revealed that 79% of practices experienced staffing shortages in breast imaging. This widespread personnel problem reduces the operational capacity of mammography clinics and forms major barriers for patients attempting to access crucial screening services, directly obstructing the market's upward trajectory.

Market Trends

A prominent trend transforming the global mammography devices market is the increasing incorporation of artificial intelligence into diagnostic routines, which boosts both operational productivity and clinical certainty. AI algorithms are being adopted more frequently to handle repetitive duties, prioritize high-risk patients, and offer decision-making assistance, optimizing the comprehensive screening procedure. This assimilation assists in mitigating the lack of radiologists and managing the surge in screening numbers. For instance, findings from the GEMINI study, featured in Nature Cancer in March 2026, showed that blending AI into screening operations reduced workloads by as much as 31% in the United Kingdom. Such productivity enhancements allow medical professionals to handle a larger caseload with current resources, speeding up patient processing and enhancing access to prompt diagnoses.

Another crucial trend involves the steady evolution of specialized imaging techniques, specifically Molecular Breast Imaging and Contrast-Enhanced Mammography. These systems supply vital secondary screening alternatives, notably for patients possessing dense breast tissue that might limit the effectiveness of standard mammography. Contrast-Enhanced Mammography delivers functional insights by illuminating blood flow within questionable lesions, while Molecular Breast Imaging employs a radioactive tracer to identify metabolically active cancer cells. Based on a 2025 review of the Density MATTERS Trial shared at ARRS 2026, Molecular Breast Imaging identified an extra 6.7 cancers per 1,000 evaluations a year following digital breast tomosynthesis. These technological enhancements broaden the diagnostic repertoire, paving the way for highly customized and successful breast cancer screening approaches.

Key Market Players

  • Hologic Inc.
  • Fujifilm Holdings Corporation
  • Philips Healthcare
  • Siemens Healthineers AG
  • GE Healthcare
  • Carestream Health Inc.
  • Konica Minolta Inc.
  • Delphinus Medical Technologies Inc.
  • Analogic Corporation
  • KUB Technologies Inc.

Report Scope

In this report, the Global Mammography Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mammography Devices Market , By Product Type

  • Full-field Digital Mammography
  • Film-screen Mammogram
  • Breast Tomosynthesis

Mammography Devices Market , By Technology

  • Digital
  • Analog

Mammography Devices Market , By End User

  • Hospitals & Clinics
  • Diagnostic Centres
  • Others

Mammography Devices Market , By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mammography Devices Market .

Available Customizations:

Global Mammography Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Mammography Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis)
    • 5.2.2. By Technology (Digital, Analog)
    • 5.2.3. By End User (Hospitals & Clinics, Diagnostic Centres, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Mammography Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Technology
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Mammography Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Mammography Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Mammography Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By End User

7. Europe Mammography Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Mammography Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By End User
    • 7.3.2. France Mammography Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Mammography Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Mammography Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Mammography Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By End User

8. Asia Pacific Mammography Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Mammography Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By End User
    • 8.3.2. India Mammography Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Mammography Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Mammography Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Mammography Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By End User

9. Middle East & Africa Mammography Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Mammography Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Mammography Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Mammography Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By End User

10. South America Mammography Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Mammography Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Mammography Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Mammography Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Mammography Devices Market : SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hologic Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Fujifilm Holdings Corporation
  • 15.3. Philips Healthcare
  • 15.4. Siemens Healthineers AG
  • 15.5. GE Healthcare
  • 15.6. Carestream Health Inc.
  • 15.7. Konica Minolta Inc.
  • 15.8. Delphinus Medical Technologies Inc.
  • 15.9. Analogic Corporation
  • 15.10. KUB Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer